疗效评估-话题@MedSci

#疗效评估#

37篇内容 | 908人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1915721, encodeId=5b401915e21cc, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=NEJM：美国北卡罗来纳州新冠肺炎疫苗接种后9个月疗效评估, objectType=article, longId=300466, objectId=b6b430046629, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6b430046629, replyNumber=0, likeNumber=49, createdTime=2022-04-14, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6b430046629, moduleTitle=NEJM：美国北卡罗来纳州新冠肺炎疫苗接种后9个月疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6b430046629)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915722, encodeId=eaa51915e22c3, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=经颅多普勒在后循环缺血性眩晕疗效评估中的应用价值, objectType=article, longId=250955, objectId=a95a2509556a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a95a2509556a, replyNumber=0, likeNumber=44, createdTime=2022-04-12, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a95a2509556a, moduleTitle=经颅多普勒在后循环缺血性眩晕疗效评估中的应用价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a95a2509556a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915716, encodeId=48111915e16e1, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=Int Arch Allergy Immunol：多过敏原皮下免疫治疗的安全性和疗效评估 , objectType=article, longId=216724, objectId=a3aa216e24a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3aa216e24a0, replyNumber=0, likeNumber=40, createdTime=2022-01-29, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3aa216e24a0, moduleTitle=Int Arch Allergy Immunol：多过敏原皮下免疫治疗的安全性和疗效评估 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3aa216e24a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915719, encodeId=62391915e1996, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=JAAD:阿巴塞普治疗斑秃的疗效评估, objectType=article, longId=217153, objectId=ba7421e1534b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba7421e1534b, replyNumber=0, likeNumber=37, createdTime=2022-03-04, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba7421e1534b, moduleTitle=JAAD:阿巴塞普治疗斑秃的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba7421e1534b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915717, encodeId=0b081915e1740, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=NEJM：美国新冠肺炎疫苗大规模接种后的疗效评估, objectType=article, longId=216889, objectId=ee21216889c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee21216889c4, replyNumber=0, likeNumber=60, createdTime=2022-03-05, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee21216889c4, moduleTitle=NEJM：美国新冠肺炎疫苗大规模接种后的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee21216889c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915720, encodeId=8d461915e2025, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=Front Oncol：可切除胰腺癌伴有淋巴结转移或R1切除使用辅助化疗续贯放化疗的疗效评估, objectType=article, longId=217585, objectId=6b7921e585b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b7921e585b6, replyNumber=0, likeNumber=46, createdTime=2022-04-23, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b7921e585b6, moduleTitle=Front Oncol：可切除胰腺癌伴有淋巴结转移或R1切除使用辅助化疗续贯放化疗的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b7921e585b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915711, encodeId=f4ab1915e1120, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=J Dermatolog Treat：红霉素凝胶联合或不联合醋酸锌治疗轻中度寻常痤疮的疗效评估, objectType=article, longId=211038, objectId=f64f211038ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f64f211038ad, replyNumber=0, likeNumber=49, createdTime=2021-08-02, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f64f211038ad, moduleTitle=J Dermatolog Treat：红霉素凝胶联合或不联合醋酸锌治疗轻中度寻常痤疮的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f64f211038ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915718, encodeId=dc801915e1870, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=JASN：甲强龙静脉注射后使用他克莫司单药治疗成人肾病综合征的疗效评估, objectType=article, longId=217104, objectId=9fe821e104f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fe821e104f9, replyNumber=0, likeNumber=59, createdTime=2022-07-07, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fe821e104f9, moduleTitle=JASN：甲强龙静脉注射后使用他克莫司单药治疗成人肾病综合征的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fe821e104f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915714, encodeId=9b0f1915e14a5, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=Eur J Cancer：不符合临床研究标准的实体恶性肿瘤患者一线免疫治疗的疗效评估, objectType=article, longId=211759, objectId=6e32211e59c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e32211e59c6, replyNumber=0, likeNumber=38, createdTime=2022-02-04, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e32211e59c6, moduleTitle=Eur J Cancer：不符合临床研究标准的实体恶性肿瘤患者一线免疫治疗的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e32211e59c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915715, encodeId=6e401915e15bb, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=JAMA：偏头痛发作期静脉注射Eptinezumab的疗效评估, objectType=article, longId=213076, objectId=3cad2130e6f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cad2130e6f7, replyNumber=0, likeNumber=31, createdTime=2021-08-16, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cad2130e6f7, moduleTitle=JAMA：偏头痛发作期静脉注射Eptinezumab的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cad2130e6f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915712, encodeId=d7421915e12c3, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=Liver Cancer: 酪氨酸激酶抑制剂（TKI）联合PD1抑制剂对初始不可切除肝细胞癌（HCC）患者的降期以及手术切除率疗效评估, objectType=article, longId=211606, objectId=ff0121160699, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff0121160699, replyNumber=0, likeNumber=51, createdTime=2021-06-08, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff0121160699, moduleTitle=Liver Cancer: 酪氨酸激酶抑制剂（TKI）联合PD1抑制剂对初始不可切除肝细胞癌（HCC）患者的降期以及手术切除率疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff0121160699)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915713, encodeId=ffa81915e13d1, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=JAMA Oncology：降低奥沙利铂/卡培他滨化疗强度对老年或体弱晚期胃食管癌患者的生活质量和疗效评估：来自GO2 III期随机临床试验结果, objectType=article, longId=211614, objectId=6cbb211614a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cbb211614a4, replyNumber=0, likeNumber=48, createdTime=2022-03-16, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cbb211614a4, moduleTitle=JAMA Oncology：降低奥沙利铂/卡培他滨化疗强度对老年或体弱晚期胃食管癌患者的生活质量和疗效评估：来自GO2 III期随机临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cbb211614a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915710, encodeId=36901915e1005, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=J Endod：采用长效氢氧化钙治疗牙髓坏死伴随根尖周炎牙齿的疗效评估, objectType=article, longId=201083, objectId=6baa2010831e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6baa2010831e, replyNumber=0, likeNumber=58, createdTime=2020-10-13, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6baa2010831e, moduleTitle=J Endod：采用长效氢氧化钙治疗牙髓坏死伴随根尖周炎牙齿的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6baa2010831e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915705, encodeId=15531915e05f9, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, objectType=article, longId=184137, objectId=74cc18413e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74cc18413e05, replyNumber=0, likeNumber=43, createdTime=2020-04-07, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74cc18413e05, moduleTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74cc18413e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915709, encodeId=63961915e09b3, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=Allergy Asthma Clin Immunol：Rupatadine在常年过敏性鼻炎患者中的疗效评估, objectType=article, longId=193913, objectId=16a5193913b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16a5193913b6, replyNumber=0, likeNumber=37, createdTime=2021-04-21, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16a5193913b6, moduleTitle=Allergy Asthma Clin Immunol：Rupatadine在常年过敏性鼻炎患者中的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16a5193913b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915707, encodeId=6aa51915e079b, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle= J Pak Med Assoc：每日一次使用他达拉非与按需使用的疗效评估是否有累积作用？, objectType=article, longId=192999, objectId=e93a19299969, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e93a19299969, replyNumber=0, likeNumber=24, createdTime=2020-04-26, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e93a19299969, moduleTitle= J Pak Med Assoc：每日一次使用他达拉非与按需使用的疗效评估是否有累积作用？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e93a19299969)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915708, encodeId=387b1915e085c, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=Lancet:4价登革热疫苗TAK-003用于4-16岁儿童疗效评估, objectType=article, longId=193614, objectId=809219361437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=809219361437, replyNumber=0, likeNumber=41, createdTime=2020-12-14, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=809219361437, moduleTitle=Lancet:4价登革热疫苗TAK-003用于4-16岁儿童疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=809219361437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915706, encodeId=da1b1915e06c3, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=NEJM：非多巴胺D2受体抗精神病药物SEP-363856疗效评估, objectType=article, longId=192413, objectId=9be519241378, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9be519241378, replyNumber=0, likeNumber=33, createdTime=2020-08-28, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9be519241378, moduleTitle=NEJM：非多巴胺D2受体抗精神病药物SEP-363856疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9be519241378)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915702, encodeId=88d51915e0256, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=Lancet oncol：新辅助药物达拉非尼联合曲美替尼疗法用于III期黑色素瘤的疗效评估, objectType=article, longId=167652, objectId=245216e65298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245216e65298, replyNumber=0, likeNumber=30, createdTime=2020-04-19, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245216e65298, moduleTitle=Lancet oncol：新辅助药物达拉非尼联合曲美替尼疗法用于III期黑色素瘤的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=245216e65298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1915703, encodeId=d6371915e032d, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, objectTitle=J Endod：使用MTA或氢氧化钙实施去龋露髓的直接盖髓术疗效评估：1年随访调查, objectType=article, longId=167778, objectId=250e16e778be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=250e16e778be, replyNumber=0, likeNumber=39, createdTime=2019-11-17, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=250e16e778be, moduleTitle=J Endod：使用MTA或氢氧化钙实施去龋露髓的直接盖髓术疗效评估：1年随访调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=250e16e778be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

疗效评估

2020-05-29

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

NEJM：美国北卡罗来纳州新冠肺炎疫苗接种后9个月疗效评估

2022-04-14

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

经颅多普勒在后循环缺血性眩晕疗效评估中的应用价值

2022-04-12

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

Int Arch Allergy Immunol：多过敏原皮下免疫治疗的安全性和疗效评估

2022-01-29

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

JAAD:阿巴塞普治疗斑秃的疗效评估

2022-03-04

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

NEJM：美国新冠肺炎疫苗大规模接种后的疗效评估

2022-03-05

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

Front Oncol：可切除胰腺癌伴有淋巴结转移或R1切除使用辅助化疗续贯放化疗的疗效评估

2022-04-23

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

J Dermatolog Treat：红霉素凝胶联合或不联合醋酸锌治疗轻中度寻常痤疮的疗效评估

2021-08-02

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

JASN：甲强龙静脉注射后使用他克莫司单药治疗成人肾病综合征的疗效评估

2022-07-07

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

Eur J Cancer：不符合临床研究标准的实体恶性肿瘤患者一线免疫治疗的疗效评估

2022-02-04

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

JAMA：偏头痛发作期静脉注射Eptinezumab的疗效评估

2021-08-16

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

Liver Cancer: 酪氨酸激酶抑制剂（TKI）联合PD1抑制剂对初始不可切除肝细胞癌（HCC）患者的降期以及手术切除率疗效评估

2021-06-08

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

JAMA Oncology：降低奥沙利铂/卡培他滨化疗强度对老年或体弱晚期胃食管癌患者的生活质量和疗效评估：来自GO2 III期随机临床试验结果

2022-03-16

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

J Endod：采用长效氢氧化钙治疗牙髓坏死伴随根尖周炎牙齿的疗效评估

2020-10-13

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR

2020-04-07

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

Allergy Asthma Clin Immunol：Rupatadine在常年过敏性鼻炎患者中的疗效评估

2021-04-21

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

J Pak Med Assoc：每日一次使用他达拉非与按需使用的疗效评估是否有累积作用？

2020-04-26

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

Lancet:4价登革热疫苗TAK-003用于4-16岁儿童疗效评估

2020-12-14

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

NEJM：非多巴胺D2受体抗精神病药物SEP-363856疗效评估

2020-08-28

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

Lancet oncol：新辅助药物达拉非尼联合曲美替尼疗法用于III期黑色素瘤的疗效评估

2020-04-19

zxxiang (审核中...)

前往app查看评论内容

#疗效评估#

J Endod：使用MTA或氢氧化钙实施去龋露髓的直接盖髓术疗效评估：1年随访调查

2019-11-17

科室
- - 订阅+
  - 更多科室
工具
服务